Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat ...

ESC Congress 2025, held together with the World Congress of Cardiology, will take place in Madrid and online from 29 August to 1 September.  A total of 10 Hot Line sessions will showcase the findings ...

High-resolution cryo-electron microscopy makes it possible to study complex enzymatic processes in detail. With this method, a research team of the University of Potsdam and Humboldt-Universität ...

Chemists use a cycle of enzymatic oxidation and chemical reduction to drive molecular rotation ...

Topline data were announced from a phase 3 trial that evaluated baxdrostat in patients with uncontrolled or treatment resistant hypertension.

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary ...

In the realm of peptide-based research, few compounds have garnered as much interdisciplinary interest as BPC-157. This ...

Key TakeawaysErythritol damages brain blood vessel cells, increasing risk of blood clots and stroke in lab studies. It ...

Researchers identified SDR42E1 as a key regulator of vitamin D absorption and sterol metabolism in colorectal cancer cells.

A phase 2 trial evaluated the efficacy and safety of lorundrostat in hypertensive patients with chronic kidney disease (CKD) and albuminuria.

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...